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Ptch1 Overexpression Drives Skin Carcinogenesis
and Developmental Defects in K14PtchFVB Mice
Hio Chung Kang1, Yuichi Wakabayashi2, Kuang-Yu Jen3, Jian-Hua Mao4, Vassilis Zoumpourlis5,
Reyno Del Rosario1 and Allan Balmain1
Ptch1 is a key regulator of embryonic development, acting through the sonic hedgehog (SHH) signaling pathway.
Ptch1 is best known as a tumor suppressor, as germline or somatic mutations in Ptch1 lead to the formation of
skin basal cell carcinomas. Here we show that Ptch1 also acts as a lineage-dependent oncogene, as over-
expression of Ptch1 in adult skin in K14PtchFVB transgenic mice synergizes with chemically induced Hras
mutations to promote squamous carcinoma development. These effects were not because of aberrant activation
of SHH signaling by the K14PtchFVB transgene, as developmental defects in the highest expressing transgenic lines
were consistent with the inhibition of this pathway. Carcinomas from K14PtchFVB transgenic mice had only a small
number of nonproliferative Ptch1 transgene-positive cells, suggesting that the Ptch1 transgene is not required for
tumor maintenance, but may have a critical role in cell-fate determination at the initiation stage.
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INTRODUCTION
Ptch1 is a key signaling receptor in the sonic hedgehog (SHH)
signaling pathway, which is critical in embryonic develop-
ment, tissue patterning, and cell-fate decisions (Ingham et al.,
1991; Chen and Struhl, 1996; Marigo et al., 1996). Mutations
resulting in loss of Ptch1 function or aberrant expression of
genes in the SHH pathway lead to developmental defects and
a cancer-prone phenotype. Germline mutations in the human
PTCH1 gene are responsible for Gorlin syndrome (also called
nevoid basal cell carcinoma syndrome), which is chara-
cterized by various developmental malformations and a high
predisposition to skin basal cell carcinoma development
(Hahn et al., 1996; Johnson et al., 1996). Mice partially
deficient in functional Ptch1 exhibit developmental
abnormalities that are comparable to those of nevoid basal
cell carcinoma syndrome patients. In addition, these mice
develop tumors such as medulloblastomas, rhabdomyosar-
comas, and basal cell carcinomas following UV or ionizing
radiation exposure, demonstrating a critical role for Ptch1 in
the regulation of developmental homeostasis and tumor
suppression (Goodrich et al., 1997; Hahn et al., 1998;
Aszterbaum et al., 1999).
We have previously identified a polymorphic variant in the
mouse Ptch1 gene (PtchFVB) that conferred susceptibility to
early postnatal squamous cell carcinoma (SCC) development
in transgenic mice expressing a mutant H-ras gene under the
control of the keratin 5 promoter (K5Hras mice) (Wakabayashi
et al., 2007). In this model, both Ptch1 and activated Ras are
expressed under the control of constitutive keratin promoters
during skin development (Byrne et al., 1994), and it remained
possible that this paradoxical effect of Ptch1 in promoting
cancer may be linked to developmental abnormalities related
to this specific model. Therefore, we tested the role of Ptch1 in
adult-onset skin tumor formation using the classical DMBA
(7,12-dimethylbenz[a]anthracene)/TPA (12-O-tetradecanoy-
lphorbol-13-acetate) model involving sporadic mutation of
the endogenous H-ras gene, rather than the high levels of
mutant H-ras expressed during development in the K5Hras
transgenic mice. Our data demonstrate that even low levels of
Ptch1 transgene expression that do not perturb expression of
Gli transcription factors promote formation of malignant SCCs.
We conclude that the SHH pathway can have either positive
or negative roles in the development of alternative tumor types
within the same tissue.
RESULTS
Developmental abnormalities in K14PtchFVB mice are consistent
with diminished Hedgehog signaling
We previously generated four different transgenic lines
(lines 6, 7, 8, and 10) expressing PtchFVB under the control
of the keratin 14 (K14) promoter at variable levels, with line 6
showing the highest Ptch1 transgene expression (Wakabayashi
et al., 2007). Initially, these transgenic lines were generated
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and maintained on the FVB/N background. Continuous
breeding to the same background resulted in poor litter
sizes, particularly in line 6 with the highest PtchFVB levels.
To maintain this line, we crossed the line 6 K14PtchFVB mice
to wild-type C57BL/6 mice and obtained litters on this hybrid
background. We observed major phenotypic abnormalities in
the line 6 K14PtchFVB mice on both FVB/N and hybrid
backgrounds. First, when compared with their wild-type
littermates, line 6 K14PtchFVB mice exhibited shorter mean
body lengths (5.6±0.48 vs. 7.9±0.25 cm, P¼0.00065 by
t-test) and lower mean body weights (5.9±0.74 vs.
14.7±0.68 g, Po0.00001 by t-test) at 4 weeks of age
(Figure 1a). This smaller body size was not visible in the other
transgenic lines apart from a slight size difference in line 8
K14PtchFVB mice (data not shown). Furthermore, although the
wild-type littermates showed normal eye development, line 6
K14PtchFVB mice clearly displayed ocular defects involving
bilateral and unilateral underdevelopment of the ocular
structures (Figure 1b). Newborn line 6 K14PtchFVB mice
exhibited either aphakia with microphthalmia (Figure 1b,
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Figure 1. Developmental abnormalities of line 6 K14PtchFVB mice. (a) Gross body size difference between K14PtchFVB and wild-type (WT) newborn
(left panel) and adult (right panel) mice. (b) Ocular developmental defect in line 6 K14PtchFVB mice. Newborn WT mice (upper left panel) display normal ocular
development with peripheral iris pigmentation and central pupil formation; newborn K14PtchFVB mice (upper center and right panels) either lack pupil formation
(arrow) or display hypoplastic ocular development. Adult K14PtchFVB mice exhibit permanently closed eyes (lower center and right panels). (c) Abnormal
limb development in line 6 K14PtchFVB mice. WT mice have five digit hindlimbs and four digit forelimbs, whereas K14PtchFVB mice have four digit hindlimbs and
three digit forelimbs.
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upper middle panel) or anophthalmia (Figure 1b, upper right
panel). Similar ocular defects have been described in mice
with mutations in Gas1, a membrane-bound glycoprotein that
is known to antagonize SHH signaling (Lee et al., 2001a, b;
Seppala et al., 2007). Adult line 6 K14PtchFVB mice
demonstrated complete and permanent closure of the
developmentally abnormal eyes (Figure 1b, lower panel).
Finally, just as limb deformities have been linked to defects
in both mouse and human genes involved in the SHH
pathway, the line 6 K14PtchFVB mice displayed abnormal
limb development (Figure 1c). Both forelimbs and hindlimbs
of line 6 K14PtchFVB mice showed oligodactyly with
fewer digits, consistent with a general inhibition of SHH
signaling during mouse development. The defective eyes
and limb deformities were not observed in line 7 and 8
K14PtchFVB mice. These phenotypic abnormalities in
Ptch1 transgenic mice are clearly opposite to those observed
in Ptch1þ /- mice or animals expressing transgenic Shh
(Goodrich et al., 1997; Oro et al., 1997). We conclude that
the Ptch1 transgene, although expressed in a subset of tissues
under the control of the K14 promoter, acts in the expected
manner as an inhibitor of SHH signaling during mouse
development.
K14PtchFVB mice develop a higher frequency of chemically
induced skin carcinomas than wild-type mice
To explore the oncogenic function for Ptch1 in the setting of
adult-onset skin carcinoma development, we performed
two-stage skin carcinogenesis by treating DMBA followed
by TPA. Because of the difficulties in breeding the line 6
transgenic mice, we carried out the carcinogenesis studies
with line 7 and 8 transgenic mice on the FVBxC57BL/6 F1
genetic background (Wakabayashi et al., 2007). By 20
weeks after treatment, both lines of K14PtchFVB transgenic
mice and wild-type mice developed a similar number of
papillomas, (Figure 2a, P¼0.89 by Kruskal–Wallis test). It is
known that a subset of benign papillomas induced by
DMBA/TPA progress to malignant SCCs or spindle cell
carcinomas (Burns et al., 1991; Oft et al., 2002). Thus, we
monitored the mice for carcinoma development for up to 50
weeks after TPA treatment. At this time point, 71% of line 7
K14PtchFVB mice and 84% of line 8 K14PtchFVB mice had
developed carcinomas, compared with only 35% of wild-
type mice (Figure 2b; P¼ 0.023 for line 7, P¼0.0011 for
line 8 by Fisher’s exact test). The carcinoma latency period
was significantly shortened in K14PtchFVB mice compared
with wild-type mice, which translated to lower carcinoma-
free survival at 50 weeks (Figure 2c, P¼ 0.0027 by Kaplan–
Meier method). The skin carcinomas were either SCCs or
spindle cell carcinomas in both K14PtchFVB and wild-type
mice, with no difference in terms of the frequency of
histological subtypes (Supplementary Table S1 online). A
hallmark of DMBA-initiated skin tumors is activating H-ras
mutations at codon 61 (CAA to CTA, Gln to Leu) (Balmain
et al., 1984; Quintanilla et al., 1986). A similar codon 61
CTA mutation frequencies was detected in carcinomas from
K14PtchFVB (24/27; 89%) and wild-type (10/11; 91%) mice
(Supplementary Table S1 online). Taken together, these data
support a positive role of Ptch1 expression in promoting
sensitivity to carcinoma development initiated by the muta-
tion of Ras in adult mice.
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Figure 2. Two-stage skin carcinogenesis in line 7 and 8 K14PtchFVB and wild-
type (WT) mice (line 7 (L7) and line 8 (L8)). (a) Papilloma development in
K14PtchFVB and wild-type mice after DMBA/TPA treatment. DMBA, 7,12-
dimethylbenz[a]anthracene; TPA, 12-O-tetradecanoylphorbol-13-acetate.
Average number of papillomas per mouse is comparable between K14PtchFVB
and WT mice at 20 weeks (P¼ 0.89, Kruskal–Wallis test). (b) Carcinoma
incidence in K14PtchFVB and WT mice. By 50 weeks after treatment, a higher
percentage of L7 and L8 K14PtchFVB mice develop skin carcinomas than WT
mice (P¼0.023 for L7; P¼ 0.0011 for L8; Fisher’s exact test). (c) Carcinoma-
free survival in K14PtchFVB (two lines: L7 and L8) and WT mice (P¼0.0027,
Kaplan–Meier method).
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Effect of oncogenic H-Ras and TPA treatment on Ptch1 binding
to Tid1
We previously showed that the product of the mouse Tid1
tumor-suppressor gene showed differential binding to
PtchFVB and PtchB6 in 293T cells (Wakabayashi et al.,
2007). To explore the possible mechanisms by which
Ptch1 expression may interact with H-Ras signaling, we
investigated the effects of H-RAS transfection or TPA
treatment on Tid1/Ptch1 binding and on the activation of
the mitogen-activated protein kinase signaling pathway.
Figure 3a shows that transfection of mutant HRAS into
293T cells led to the accumulation of the GTP-bound form
of RAS, but surprisingly had only a minor effect on
activation of phospho-extracellular signal–regulated kinase
(p-ERK) (Figure 3a, lanes 1 and 2). Co-transfection of Ptch1
(PtchFVB or PtchB6) in this assay led to only a modest but
reproducible stimulation of p-ERK, and this was increased
slightly by co-transfection of oncogenic V12HRAS. In
parallel experiments, oncogenic HRAS had little influence
on the binding of Tid1 to PtchFVB or PtchB6as shown by co-
immunoprecipitation assays (Figure 3b). However, TPA
treatment, which had a very strong effect on the activation
of p-ERK (Figure 3c, second to bottom panels), destabilized
the strong binding between Tid1 and Ptch1, especially for
the PtchB6 variant (Figure 3c, lanes 3 and 4). This reduced
level of binding, seen both at 30 minutes and 1 hour after
TPA treatment, was more similar to that seen with the FVB
variant protein, suggesting that activation of HRAS/mitogen-
activated protein kinase signaling may directly affect the
stability of the Ptch1/Tid1 complex.
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Figure 3. Effect of oncogenic H-Ras and 12-O-tetradecanoylphorbol-13-acetate (TPA) treatment in cells overexpressing PtchFVB or PtchB6. (a) 293T cells were
transiently co-transfected with hemagglutinin (HA)-tagged PtchFVB or PtchB6 and oncogenic V12HRAS. Mitogen-activated protein kinase (MAPK) signaling was
examined by western blotting. Co-transfection of Ptch1 (PtchFVB or PtchB6) in this assay led to only a modest but reproducible stimulation of phospho-extracellular
signal–regulated kinase (p-ERK), and this was increased slightly in the presence of oncogenic V12HRAS. t-ERK1/2, total ERK1/2. (b) Oncogenic V12HRAS
had little effect on the differential binding of Tid1 to PtchFVB or PtchB6 by immunoprecipitation (IP) with anti-Tid1 and anti-HA antibodies. IB, immunoblotting.
(c) IP showed that TPA treatment, which had a very strong effect on the activation of p-ERK, destabilized the strong binding between Tid1 and Ptch1, especially
for the PtchB6 variant.
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Gene expression analysis of SHH signaling targets in K14PtchFVB
mouse skin and skin carcinomas
Loss of the inhibitory function of Ptch1 in the SHH signaling
pathway results in upregulation of Gli1, Gli2, and Ptch1 itself
(Dahmane et al., 1997; Aszterbaum et al., 1999). To
investigate whether Ptch1 overexpression in skin and skin
SCCs gives rise to perturbations in SHH signaling, we
performed quantitative real-time reverse transcriptase–PCR
for the major target genes Ptch1, Gli1, Gli2, as well as Ccnb1
(cyclin B1), which was proposed to act together with Ptch1 in
regulating the cell cycle (Barnes et al., 2001). Although the
average transcript level of total Ptch1 was elevated in the skin
(Figure 4a, Po0.0001 by t-test), and to a lesser extent also in
skin cancers from K14PtchFVB mice (Figure 4b, P¼ 0.0014 by
t-test), Gli1 and Gli2 levels in skin (Figure 4a) and skin
carcinomas (Figure 4b) were comparable between K14PtchFVB
and wild-type mice. The average Ccnb1 transcript level was
not different between the two genotypes, both in normal skin
and in skin tumors (Figure 4a and b). We conclude that all
of these known SHH pathway candidate genes are not
significantly disrupted in expression levels, at least at the
whole tissue level, in Ptch1 transgenic skins.
To investigate other possible consequences of Ptch1 over-
expression in K14PtchFVB mice, we chose candidate genes on
the basis of correlation in transcript levels with Ptch1 in normal
skin from interspecific backcross mice (Quigley et al., 2009;
additional data not shown). We performed quantitative real-
time reverse transcriptase–PCR analysis for eight candidate
genes—Bmp6, Bnc2, Hdgfrp3, Nt5e, Sox4, Gli3, Lphn1, and
Ncdn— all of which were significantly correlated with Ptch1
expression in normal skin. The expression analysis showed that
only the Sox4 transcript level was significantly decreased in
adult skins of K14PtchFVB mice compared with controls
(Figure 4c, P¼ 0.001 by t-test), but no difference was seen in
skin carcinomas (Figure 4b). This reduced level of Sox4 was
also seen, but to a lesser extent, in newborn skins from line 6
and 8 K14PtchFVB mice (Figure 4d, P¼0.023 by t-test).
Presence of Ptch1 transgene-positive cells in skin carcinomas
To examine Ptch1 transgene expression at the cellular level in
skin and skin carcinomas from transgenic mice, we carried out
an immunohistochemical analysis using antibodies against the
hemagglutinin (HA) tag present at the C-terminus of the Ptch1
transgene. Cells positive for anti-HA were simultaneously
positive for anti-Ptch1 by co-staining. First, we evaluated
normal skin from the K14PtchFVB transgenic lines for the
presence of HA/Ptch-positive epithelial cells. Of the three
K14PtchFVB transgenic lines, a small number of HA/Ptch-
positive cells was only detectable in skin from line 6
K14PtchFVB mice (Figure 5a). These HA/Ptch-positive cells
were clustered in small foci rather than being scattered as
single cells at the basal layer of the epidermis (Figure 5a). On
the other hand, no HA-positive cells were identified in skin
from line 7 and 8 K14PtchFVB mice. It appears that although
the Ptch1 mRNA level remains elevated in adult skin from
K14PtchFVB mice compared with wild-type mice, significant
protein expression is only detectable in clusters of epidermal
cells during development.
Next we examined the presence of HA/Ptch-positive cells in
skin carcinomas from K14PtchFVB mice. Of the 24 transgenic
mouse carcinomas tested, 20 (83%) showed small clusters of
HA/Ptch-positive cells, but none were detected in carcinomas
from wild-type mice (Supplementary Table S1 online). These
cells were mainly detected in SCCs, and if present in spindle
cell carcinomas, they were predominantly in areas of the
tumor that showed squamous differentiation (Figure 5b and c).
In the SCCs, the HA/Ptch-positive cells were located at the
superficial aspect of the spinous layer, near the interface with
the keratinized/cornified cells (Figure 5b), particularly in
tumor regions with strong K14 expression (Figure 6a). The
cell proliferation marker, Ki67, was frequently expressed in
the skin cancer cells, but the HA/Ptch-positive cells (78–
100%) were largely negative for Ki67 expression (Figure 6b),
indicating that these cells are likely nonproliferative. We also
performed co-staining of the known skin stem cell markers,
Sox2, Pax6, or Cd34, with the HA/Ptch tag (Li et al., 2005;
Takahashi and Yamanaka, 2006; Malanchi et al., 2008). Some
HA/Ptch-positive cells showed co-staining with Sox2 and
Pax6, but the pattern was essentially random (Figure 6c),
and these cells were largely negative for Cd34 (Figure 6c). We
conclude that any HA/Ptch-positive cells that are found in skin
carcinomas are predominantly terminally differentiated cells
with no significant proliferative and stem cell–like activity.
DISCUSSION
In this study, we have explored the paradoxical role of
exogenous Ptch1 expression in promoting Ras-driven SCC
development. Line 6 K14PtchFVB mice with the highest Ptch1
overexpression had severe developmental defects, including
growth retardation, loss of digits in the forelimbs and
hindlimbs, and abnormalities of the eyes. The similarity
between these phenotypes and those caused by germline
mutations leading to loss of the SHH pathway function
(Chiang et al., 1996; Chiang et al., 2001; Zhang et al.,
2001) indicates that the expression of Ptch1 driven by the
K14 promoter during development (Kopan and Fuchs, 1989;
Byrne et al., 1994) results in perturbation of Shh signaling by
either cell autonomous or non-cell autonomous mechanisms,
leading to the observed major developmental abnormalities in
developing epithelia.
Skin tumor susceptibility studies were conducted on two
transgenic lines (lines 7 and 8), in which Ptch1 transgene
expression was relatively low. Nevertheless, these lines were
found to be highly susceptible to chemically induced carci-
nomas of the skin in a two-stage carcinogenesis study. Gene
expression analysis detected no changes in the major down-
stream effectors of SHH signaling, such as Gli1 or Gli2, in
adult skin, although it remains possible that single cells or
clusters of Ptch1-positive cells in transgenic skin could express
the altered levels of these markers. Of the other candidate
genes selected on the basis of correlations with Ptch1 expres-
sion in heterogeneous mouse populations (Quigley et al,
2009), only Sox4 was expressed at lower level in the skins
of K14PtchFVB mice. A previous study suggested that PTCH1 is
one of the SOX4 transcriptional target genes (Scharer et al.,
2009), and coexpression of Sox4 and Shh in the developing
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hair germ was observed (Kobielak et al., 2007). Therefore, it is
possible that one consequence of Ptch1 overexpression is
deregulation of stem cell dynamics through a feedback
leading to altered Sox4 expression in K14PtchFVB mice. At
the molecular level, in vitro studies using human 293T cells
indicated that one possible mechanism by which Ptch1 and
the Ras pathway interact is through the modulation of
mitogen-activated protein kinase signaling. Strong activation
of p-ERK by TPA led to disruption of the previously reported
strong binding of the Ptch1 PtchB6 variant to mTid1
(Wakabayashi et al., 2007), a tumor-suppressor protein
originally discovered in Drosophila (Canamasas et al.,
2003). It is possible that activation of Ras/mitogen-activated
protein kinase signaling alleviates the tumor-suppressor
functions of Tid1 through reduction of its interaction with
Ptch. Further studies using conditional knockout alleles will be
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Figure 4. Quantitative real-time reverse transcriptase–PCR (qRT–PCR) analysis of the candidate sonic hedgehog (SHH) signaling targets. (a) Ptch1, Gli1,
Gli2, and Ccnb1 transcript levels in skins from K14PtchFVB (n¼14) and wild-type (WT; n¼6) mice. Ptch1 expression is significantly elevated in the skins of
K14PtchFVB mice (Po0.0001 by t-test). (b) Average Ptch1, Gli1, Gli2, Ccnb1, and Sox4 transcript levels in skin cancers from K14PtchFVB and WT mice. Ptch1
expression is also elevated in skin carcinomas from K14PtchFVB mice (P¼ 0.0014 by t-test). (c) Analysis of Bmp6, Bnc2, Hdgfrp3, Nt5e, Sox4, Gli3, Lphn1,
and Ncdn transcript levels in adult skins from K14PtchFVB and WT mice. The average Sox4 transcript level is significantly decreased in adult skins of K14PtchFVB
mice (P¼0.001 by t-test). (d) Average Bmp6, Bnc2, Hdgfrp3, Nt5e, Sox4, Gli3, Lphn1, and Ncdn transcript levels in newborn skins from K14PtchFVB (n¼ 5)
and WT (n¼ 5) mice. The average Sox4 transcript level is also slightly lower in newborn skins of K14PtchFVB mice (P¼0.023 by t-test). Statistical significance
is indicated as **Po0.001; *Po0.05 by t-test.
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required to determine whether similar mechanisms have a role
in promoting the growth of Ras-initiated cells in mouse skin.
We also tested the possibility that the subpopulation of cells
within carcinomas that continued to express the Ptch1
transgene might be involved in tumor maintenance, or express
markers of skin stem cells. However, these cells were only
found in very well-differentiated tumors, or in highly differ-
entiated cells within more aggressive tumors. They were
negative for expression of cell cycle marker, suggesting that
they do not display proliferative activity and were also
negative for markers, such as Cd34, Pax6, and Sox2, which
have been implicated in control of skin stem cells. These data
are compatible with the interpretation that the Ptch1 transgene
expression, although clearly acting to promote SCC develop-
ment, is no longer required for the maintenance of these
tumors and is silenced during tumor progression.
Our data are compatible with the hypothesis that the SHH
pathway, when activated through loss of Ptch1 or activation of
downstream effectors, such as Smoothened (Smo) or Gli1/2,
leads to increased susceptibility to basal cell carcinoma
formation by promoting the cell-fate decision leading to the
appropriate cell of origin for these tumors. The overexpression
of Ptch1, however, promotes an alternative epidermal cell-fate
decision leading to increased SCC formation. The concept that
HA Ptch Merged MergedDAPI
43H-H&E 43H-HAPtchDAPI
31H-H&E 31H-HAPtchDAPI
21H-HA 21H-Ptch 21H-mergedDAPI
a
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c
Figure 5. Hemagglutinin (HA)/Ptch-positive cells in the normal skin and skin carcinomas of K14PtchFVB mice. (a) HA/Ptch-positive cells (dotted circles) in normal
skin from line 6 K14PtchFVB mice by immunohistochemical analysis. (b) HA/Ptch-positive cells (arrows and dotted circles) in squamous cell carcinomas (SCCs)
from line 7 and 8 K14PtchFVB mice by immunohistochemical analysis. In the SCCs, the HA/Ptch-positive cells were often located at the superficial aspect of
the spinous layer, near the interface with the keratinized/cornified cells. Parallel hematoxylin and eosin (H&E)-stained section (upper left panel) reveals well-
differentiated SCCs. (c) HA/Ptch-positive cells (dotted circle and embedded image with higher magnification) are present in the squamous epithelium adjacent to
a spindle cell carcinoma. No HA/Ptch staining is seen in the spindled carcinoma cells. DAPI, 4,6-diamidino-2-phenylindole. Scale bar¼ 50mm.
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developmental regulators that promote one particular lineage
can also simultaneously suppress an alternative lineage is well
known (Davidson, 2010). Such a mechanism may have an
important influence on susceptibility to different types of
tumors in the same tissue, conferring susceptibility to one
type but resistance to an alternative tumor arising from a
different lineage. Polymorphisms in genes that influence
alternative cell-fate decisions may therefore have an
important role in determining individual tumor susceptibility
at an early stage of carcinogenesis.
MATERIALS AND METHODS
Mice, tumor induction, and histological analysis
All animal experiments were conducted under the approval of the
Institutional Animal Care and Use Committee of the University of
California, San Francisco. The original K14PtchFVB mice from lines 6,
51H-HA 51H-K14 51H-merged
59H-HA 59H-K14 59H-merged
a
b 57H-HAKi67 21H-HAKi67
c 21H-HA 21H-
Sox2
21H-merged
59H-HA 59H-
Pax6
59H-merged
21H-HA 21H-
Cd34
21H-merged
Figure 6. Co-staining of the hemagglutinin (HA)/Ptch-positive cells with keratin 14 (K14), Ki67, or stem cell markers in squamous cell carcinomas (SCCs) from
K14PtchFVB mice. Arrows and dotted circles indicate HA/Ptch-positive cells. (a) Co-staining of HA and K14-positive cells. The HA/Ptch-positive cells are located
in SCCs with strong K14 expression. (b) Co-staining of HA- and Ki67-positive cells. The HA-positive cells (dotted circles) are negative for Ki67 expression.
(c) Co-staining of HA with stem cell markers, Sox2, Pax6, or Cd34 antibodies. Scale bar¼ 50mm.
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7, and 8 were previously described (Wakabayashi et al., 2007). Lines 7
and 8 were maintained on the FVB/N background and crossed with
C57BL/6 mice to generate F1 wild-type and K14PtchFVB mice for two-
stage chemical carcinogenesis. A total of 23 line 7 K14PtchFVB and 26
line 8 K14PtchFVB mice along with 35 wild-type mice (combined from
both lines) were used to induce chemical carcinogenesis. Mice were
genotyped using PCR primers previously described (Wakabayashi
et al., 2007). To induce skin carcinogenesis, a single dose of DMBA
was topically applied at 8 weeks of age followed by twice-weekly
application of TPA for 20 weeks as described (Balmain et al., 1984;
Quintanilla et al., 1986). Papilloma number was recorded from 10
weeks after DMBA up to 20 weeks and carcinoma development was
monitored up to 50 weeks after TPA treatment. Mice were killed if
they were moribund, if there were excessive tumor loads, if any single
tumor exceeded 1.5 cm in diameter, or at the termination of the
experiment. Tumors removed by surgical dissection were immediately
snap-frozen in liquid nitrogen or fixed in 10% buffered formalin
solution for further analysis. Paraffin-embedded tumor sections were
stained with hematoxylin and eosin for histopathological analyses.
DNA and RNA extraction
Frozen skin and tumor specimens were powdered in liquid nitrogen
with pestle and mortar and homogenized for DNA and RNA
preparation. For RNA extraction, specimens were homogenized and
dissolved in TRIzol Reagent (Invitrogen, Carlsbad, CA) and purified
for RNA isolation according to the manufacturer’s instructions.
Genomic DNA was isolated using standard phenol/chloroform
extraction following an overnight incubation at 55 1C with Proteinase
K (Sigma, St Louis, MO) in a lysis buffer (50 mM Tris at pH 8.0,
100 mM EDTA, 100 mM NaCl, and 1% SDS).
H-ras mutation analysis
To determine a specific H-ras mutation, CAA to CTA at codon 61,
exon 2 of the H-ras gene was amplified using the primers previously
described (Nagase et al., 2003). Amplified PCR fragments were
digested with restriction enzyme XbaI (NEB, Ipswich, MA) at 37 1C
for 2 hours and electrophoresed in a 4% Nusieve 3:1 agarose gel
(Lonza, Walkersville, MD).
Cell culture and transfection
293T cells were grown at 37 1C in DMEM supplemented with 10%
fetal bovine serum, penicillin, streptomycin, and glutamine, and
maintained in a humidified atmosphere of 5% CO2. HA-tagged
PtchFVB and PtchB6 constructs in pcDNA3.1 and pLXSP3 retrovirus
expressing V12HRAS were previously described (Wakabayashi et al.,
2007). For transient transfection or co-transfection, Lipofectamine 2000
was used according to the manufacturer’s instructions (Invitrogen).
Western blotting, immunoprecipitation, and Ras-GTP assays
Western blotting was performed as previously described
(Wakabayashi et al., 2007). Antibodies ERK1/2 (137F5), p-ERK1/2
(20G11), Tid1 (RS13 and RS-11), H-Ras (C-20, sc-520), HA-tag
(mouse monoclonal 6E2 and goat polyclonal ab9134), and b-actin
(from Sigma) were used. For TPA treatment, transfected 293T cells
were incubated with 500 nM of TPA for 30 minutes and 1 hour. For
immunoprecipitation, 500mg of lysates were processed with HA Tag
IP/Co-IP kit (Thermo Scientific, Waltham, MA) and Dynabeads
Protein G IP kit (Invitrogen) according to the manufacturers’
instructions. For Ras-GTP assay, cells were washed with ice-cold
phosphate-buffered saline and lysed in 1 MLB (Magnesium-
containing Lysis Buffer) with protease and phosphatase inhibitor
cocktails. Raf-RBD pull down was performed with Ras Activation
Assay kit containing Raf-1 RBD agarose beads according to the
manufacturer’s manual (EMD Millipore, Billerica, MA).
Expression analysis for SHH signaling targets
Single-strand complementary DNAs were synthesized from 1mg
of DNase-treated total RNA from skins and skin carcinomas
using SuperScript III First-Strand Synthesis System (Invitrogen)
according to the manufacturer’s manual. Predesigned TaqMan
probes and primers for Ptch1 (Mm01306905), Gli1 (Mm00494654),
Gli2 (Mm01293111), Ccnb1 (Mm00838401), Sox4 (Mm00486317),
Bmp6 (Mm01332882), Bnc2 (Mm01266537), Nt5e (Mm00501917),
Hdgfrp3 (Mm01324333), Gli3 (Mm00492345), Lphn1 (Mm00492345),
Ncdn (Mm00449529), Actb (b-actin, 4352933E), and glyceraldehyde-
3-phosphate dehydrogenase (Mm99999915) were used for quantita-
tive real-time reverse transcriptase–PCR analysis (ABI, Foster City,
CA). Amplification of complementary DNAs was carried out in
triplicate for each sample in the ABI 7900HT system according to
the manufacturer’s protocol. The normalized transcript level was
determined by calculating DCt values by subtracting mean Ct values
of target genes with mean Ct values of housekeeping genes. Then, 1/
DCt values were used to obtain representative values indicating higher
values to higher transcript levels.
Immunofluorescence
Skin and carcinoma specimens were fixed in buffered formalin
solution and processed for paraffin embedding. Sections (5mm in
thickness) were deparaffinized with xylene two times for 10 minutes
and processed in a pressure cooker for antigen retrieval using Triology
solution (Cell Marques, Rocklin, CA). The sections were blocked in
10% donkey serum supplemented with 0.3% Triton X-100 for 1 hour
and incubated with primary antibody (HA tags, goat; Abcam,
Cambridge, MA) for 1 hour at room temperature. After rinse
with phosphate-buffered saline, the sections were incubated with
FITC-conjugated secondary antibody for 1 hour at room temperature.
For double staining, HA-tag incorporated sections were further
blocked in 10% goat serum supplemented with 0.3% Triton X-100
for 1 hour and incubated with rabbit Ptch1 (Abcam), Ki67 (Neomar-
kers, Fremont, CA), K14 (Covance, Princeton, NJ), Sox2 (Abcam),
Pax6 (Abcam), or Cd34 (rat, BD Pharmingen, San Diego, CA)
antibodies. After rinse with phosphate-buffered saline, the sections
were incubated with Alexa 555-conjugated anti-rabbit or anti-rat
secondary antibodies followed by 4,6-diamidino-2-phenylindole
staining. The section images were examined under the fluorescent
microscope (Olympus BX60, Center Valley, PA).
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